Various glycolysis inhibitor-containing tubes for glucose measurement cannot be used interchangeably due to clinically unacceptable biases between them

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Need for better PTH assays for clinical research and patient treatment
4. Reviews
5. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
6. Hair testing of GHB: an everlasting issue in forensic toxicology
7. Opinion Paper
8. The use of error and uncertainty methods in the medical laboratory
9. Genetics and Molecular Diagnostics
10. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
11. The importance of biochemical and genetic findings in the diagnosis of atypical Norrie disease
12. General Clinical Chemistry and Laboratory Medicine
13. Various glycolysis inhibitor-containing tubes for glucose measurement cannot be used interchangeably due to clinically unacceptable biases between them
14. Measurement uncertainty of γ-glutamyltransferase (GGT) in human serum by four approaches using different quality assessment data
15. Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
16. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum
17. The key incident monitoring and management system – history and role in quality improvement
18. Is it necessary for all samples to quantify 25OHD₂ and 25OHD₃ using LC-MS/MS in clinical practice?
19. Contamination of dried blood spots – an underestimated risk in newborn screening
20. Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays
21. Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies
22. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
23. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods
24. Hematology and Coagulation
25. The frequency of occurrence of fish-shaped red blood cells in different haematologic disorders
26. Reference Values and Biological Variations
27. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents
28. Cancer Diagnostics
29. Prevalence and causes of abnormal PSA recovery
30. Cardiovascular Diseases
31. Serum omentin-1 is a novel biomarker for predicting the functional outcome of acute ischemic stroke patients
32. Letters to the Editor
33. BD Vacutainer^® Barricor tube in the emergency department: reduced hemolysis rates using partial draw tubes with reduced vacuum
34. The risk of unjustified BRCA testing after the “Angelina Jolie effect”: how can we save (laboratory) medicine from the Internet?
35. Sweat travels: the issue of sweat chloride transportation
36. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays
37. False negative results caused by erroneous automated result interpretation algorithm on the FilmArray 2.0 instrument
38. Quantification of 1,25-dihydroxyvitamin D – value of manufacturers’ product information
39. Interference between ethosuximide and barbiturates in an immunochromatographic method
40. In vivo interference of Ioversol in serum and urine capillary electrophoresis: an optimized protocol for sample collection
41. Evaluation of the new Elecsys SCC assay: comparison with the Kryptor SCC assay
42. Congress Abstracts
43. 9th National Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine
44. ACBI 2017 40^TH Annual Conference